Pharma & Healthcare
Brucella Abortus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 18, 24
- ID: 554398
- Pages: 157
- Figures: 292
- Views: 1
The global market for Brucella Abortus Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Brucella Abortus Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Brucella Abortus Vaccine by region & country, by Type, and by Application.
The Brucella Abortus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brucella Abortus Vaccine.
Market Segmentation
By Company
Zoetis
CEVA
Merck Animal Health
Biovet
CAVAC
JOVAC
Merial
Colorado Serum Company
VECOL
Tecnovax
Indian Immunologicals
Vetal
Dollvet
Centro Diagnostico Veterinario
Onderstepoort Biological Products
Institute of Animal Health and Veterinary Biologicals
Biogenesis Bago
Instituto Rosenbusch
SYVA Laboratorios
CZ Veterinaria
Hester Biosciences
Qilu Animal Health
Segment by Type:
DNA Vaccines
Subunit Vaccines
Vector Vaccines
B. Abortus Recombinant Mutants
Others
Segment by Application
Cattles
Sheep
Pigs
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Brucella Abortus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Brucella Abortus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Brucella Abortus Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Brucella Abortus Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Brucella Abortus Vaccine by region & country, by Type, and by Application.
The Brucella Abortus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brucella Abortus Vaccine.
Market Segmentation
By Company
Zoetis
CEVA
Merck Animal Health
Biovet
CAVAC
JOVAC
Merial
Colorado Serum Company
VECOL
Tecnovax
Indian Immunologicals
Vetal
Dollvet
Centro Diagnostico Veterinario
Onderstepoort Biological Products
Institute of Animal Health and Veterinary Biologicals
Biogenesis Bago
Instituto Rosenbusch
SYVA Laboratorios
CZ Veterinaria
Hester Biosciences
Qilu Animal Health
Segment by Type:
DNA Vaccines
Subunit Vaccines
Vector Vaccines
B. Abortus Recombinant Mutants
Others
Segment by Application
Cattles
Sheep
Pigs
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Brucella Abortus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Brucella Abortus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Brucella Abortus Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Brucella Abortus Vaccine Product Introduction
1.2 Global Brucella Abortus Vaccine Market Size Forecast
1.2.1 Global Brucella Abortus Vaccine Sales Value (2019-2030)
1.2.2 Global Brucella Abortus Vaccine Sales Volume (2019-2030)
1.2.3 Global Brucella Abortus Vaccine Sales Price (2019-2030)
1.3 Brucella Abortus Vaccine Market Trends & Drivers
1.3.1 Brucella Abortus Vaccine Industry Trends
1.3.2 Brucella Abortus Vaccine Market Drivers & Opportunity
1.3.3 Brucella Abortus Vaccine Market Challenges
1.3.4 Brucella Abortus Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Brucella Abortus Vaccine Players Revenue Ranking (2023)
2.2 Global Brucella Abortus Vaccine Revenue by Company (2019-2024)
2.3 Global Brucella Abortus Vaccine Players Sales Volume Ranking (2023)
2.4 Global Brucella Abortus Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Brucella Abortus Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Brucella Abortus Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Brucella Abortus Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Brucella Abortus Vaccine
2.9 Brucella Abortus Vaccine Market Competitive Analysis
2.9.1 Brucella Abortus Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Brucella Abortus Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucella Abortus Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 DNA Vaccines
3.1.2 Subunit Vaccines
3.1.3 Vector Vaccines
3.1.4 B. Abortus Recombinant Mutants
3.1.5 Others
3.2 Global Brucella Abortus Vaccine Sales Value by Type
3.2.1 Global Brucella Abortus Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Brucella Abortus Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Brucella Abortus Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Brucella Abortus Vaccine Sales Volume by Type
3.3.1 Global Brucella Abortus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Brucella Abortus Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Brucella Abortus Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Brucella Abortus Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cattles
4.1.2 Sheep
4.1.3 Pigs
4.1.4 Others
4.2 Global Brucella Abortus Vaccine Sales Value by Application
4.2.1 Global Brucella Abortus Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Brucella Abortus Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Brucella Abortus Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Brucella Abortus Vaccine Sales Volume by Application
4.3.1 Global Brucella Abortus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Brucella Abortus Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Brucella Abortus Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Brucella Abortus Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Brucella Abortus Vaccine Sales Value by Region
5.1.1 Global Brucella Abortus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Brucella Abortus Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Brucella Abortus Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Brucella Abortus Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Brucella Abortus Vaccine Sales Volume by Region
5.2.1 Global Brucella Abortus Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Brucella Abortus Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Brucella Abortus Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Brucella Abortus Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Brucella Abortus Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Brucella Abortus Vaccine Sales Value, 2019-2030
5.4.2 North America Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Brucella Abortus Vaccine Sales Value, 2019-2030
5.5.2 Europe Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Brucella Abortus Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Brucella Abortus Vaccine Sales Value, 2019-2030
5.7.2 South America Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Brucella Abortus Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Brucella Abortus Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Brucella Abortus Vaccine Sales Value
6.2.1 Key Countries/Regions Brucella Abortus Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Brucella Abortus Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Brucella Abortus Vaccine Sales Value, 2019-2030
6.3.2 United States Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Brucella Abortus Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Brucella Abortus Vaccine Sales Value, 2019-2030
6.4.2 Europe Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Brucella Abortus Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Brucella Abortus Vaccine Sales Value, 2019-2030
6.5.2 China Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Brucella Abortus Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Brucella Abortus Vaccine Sales Value, 2019-2030
6.6.2 Japan Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Brucella Abortus Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Brucella Abortus Vaccine Sales Value, 2019-2030
6.7.2 South Korea Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Brucella Abortus Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Brucella Abortus Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Brucella Abortus Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Brucella Abortus Vaccine Sales Value, 2019-2030
6.9.2 India Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Brucella Abortus Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Company Information
7.1.2 Zoetis Introduction and Business Overview
7.1.3 Zoetis Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Zoetis Brucella Abortus Vaccine Product Offerings
7.1.5 Zoetis Recent Development
7.2 CEVA
7.2.1 CEVA Company Information
7.2.2 CEVA Introduction and Business Overview
7.2.3 CEVA Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 CEVA Brucella Abortus Vaccine Product Offerings
7.2.5 CEVA Recent Development
7.3 Merck Animal Health
7.3.1 Merck Animal Health Company Information
7.3.2 Merck Animal Health Introduction and Business Overview
7.3.3 Merck Animal Health Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Merck Animal Health Brucella Abortus Vaccine Product Offerings
7.3.5 Merck Animal Health Recent Development
7.4 Biovet
7.4.1 Biovet Company Information
7.4.2 Biovet Introduction and Business Overview
7.4.3 Biovet Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Biovet Brucella Abortus Vaccine Product Offerings
7.4.5 Biovet Recent Development
7.5 CAVAC
7.5.1 CAVAC Company Information
7.5.2 CAVAC Introduction and Business Overview
7.5.3 CAVAC Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 CAVAC Brucella Abortus Vaccine Product Offerings
7.5.5 CAVAC Recent Development
7.6 JOVAC
7.6.1 JOVAC Company Information
7.6.2 JOVAC Introduction and Business Overview
7.6.3 JOVAC Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 JOVAC Brucella Abortus Vaccine Product Offerings
7.6.5 JOVAC Recent Development
7.7 Merial
7.7.1 Merial Company Information
7.7.2 Merial Introduction and Business Overview
7.7.3 Merial Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Merial Brucella Abortus Vaccine Product Offerings
7.7.5 Merial Recent Development
7.8 Colorado Serum Company
7.8.1 Colorado Serum Company Company Information
7.8.2 Colorado Serum Company Introduction and Business Overview
7.8.3 Colorado Serum Company Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Colorado Serum Company Brucella Abortus Vaccine Product Offerings
7.8.5 Colorado Serum Company Recent Development
7.9 VECOL
7.9.1 VECOL Company Information
7.9.2 VECOL Introduction and Business Overview
7.9.3 VECOL Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 VECOL Brucella Abortus Vaccine Product Offerings
7.9.5 VECOL Recent Development
7.10 Tecnovax
7.10.1 Tecnovax Company Information
7.10.2 Tecnovax Introduction and Business Overview
7.10.3 Tecnovax Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Tecnovax Brucella Abortus Vaccine Product Offerings
7.10.5 Tecnovax Recent Development
7.11 Indian Immunologicals
7.11.1 Indian Immunologicals Company Information
7.11.2 Indian Immunologicals Introduction and Business Overview
7.11.3 Indian Immunologicals Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Indian Immunologicals Brucella Abortus Vaccine Product Offerings
7.11.5 Indian Immunologicals Recent Development
7.12 Vetal
7.12.1 Vetal Company Information
7.12.2 Vetal Introduction and Business Overview
7.12.3 Vetal Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Vetal Brucella Abortus Vaccine Product Offerings
7.12.5 Vetal Recent Development
7.13 Dollvet
7.13.1 Dollvet Company Information
7.13.2 Dollvet Introduction and Business Overview
7.13.3 Dollvet Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Dollvet Brucella Abortus Vaccine Product Offerings
7.13.5 Dollvet Recent Development
7.14 Centro Diagnostico Veterinario
7.14.1 Centro Diagnostico Veterinario Company Information
7.14.2 Centro Diagnostico Veterinario Introduction and Business Overview
7.14.3 Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Offerings
7.14.5 Centro Diagnostico Veterinario Recent Development
7.15 Onderstepoort Biological Products
7.15.1 Onderstepoort Biological Products Company Information
7.15.2 Onderstepoort Biological Products Introduction and Business Overview
7.15.3 Onderstepoort Biological Products Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Onderstepoort Biological Products Brucella Abortus Vaccine Product Offerings
7.15.5 Onderstepoort Biological Products Recent Development
7.16 Institute of Animal Health and Veterinary Biologicals
7.16.1 Institute of Animal Health and Veterinary Biologicals Company Information
7.16.2 Institute of Animal Health and Veterinary Biologicals Introduction and Business Overview
7.16.3 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Offerings
7.16.5 Institute of Animal Health and Veterinary Biologicals Recent Development
7.17 Biogenesis Bago
7.17.1 Biogenesis Bago Company Information
7.17.2 Biogenesis Bago Introduction and Business Overview
7.17.3 Biogenesis Bago Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Biogenesis Bago Brucella Abortus Vaccine Product Offerings
7.17.5 Biogenesis Bago Recent Development
7.18 Instituto Rosenbusch
7.18.1 Instituto Rosenbusch Company Information
7.18.2 Instituto Rosenbusch Introduction and Business Overview
7.18.3 Instituto Rosenbusch Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Instituto Rosenbusch Brucella Abortus Vaccine Product Offerings
7.18.5 Instituto Rosenbusch Recent Development
7.19 SYVA Laboratorios
7.19.1 SYVA Laboratorios Company Information
7.19.2 SYVA Laboratorios Introduction and Business Overview
7.19.3 SYVA Laboratorios Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.19.4 SYVA Laboratorios Brucella Abortus Vaccine Product Offerings
7.19.5 SYVA Laboratorios Recent Development
7.20 CZ Veterinaria
7.20.1 CZ Veterinaria Company Information
7.20.2 CZ Veterinaria Introduction and Business Overview
7.20.3 CZ Veterinaria Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.20.4 CZ Veterinaria Brucella Abortus Vaccine Product Offerings
7.20.5 CZ Veterinaria Recent Development
7.21 Hester Biosciences
7.21.1 Hester Biosciences Company Information
7.21.2 Hester Biosciences Introduction and Business Overview
7.21.3 Hester Biosciences Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Hester Biosciences Brucella Abortus Vaccine Product Offerings
7.21.5 Hester Biosciences Recent Development
7.22 Qilu Animal Health
7.22.1 Qilu Animal Health Company Information
7.22.2 Qilu Animal Health Introduction and Business Overview
7.22.3 Qilu Animal Health Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Qilu Animal Health Brucella Abortus Vaccine Product Offerings
7.22.5 Qilu Animal Health Recent Development
8 Industry Chain Analysis
8.1 Brucella Abortus Vaccine Industrial Chain
8.2 Brucella Abortus Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Brucella Abortus Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Brucella Abortus Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Brucella Abortus Vaccine Product Introduction
1.2 Global Brucella Abortus Vaccine Market Size Forecast
1.2.1 Global Brucella Abortus Vaccine Sales Value (2019-2030)
1.2.2 Global Brucella Abortus Vaccine Sales Volume (2019-2030)
1.2.3 Global Brucella Abortus Vaccine Sales Price (2019-2030)
1.3 Brucella Abortus Vaccine Market Trends & Drivers
1.3.1 Brucella Abortus Vaccine Industry Trends
1.3.2 Brucella Abortus Vaccine Market Drivers & Opportunity
1.3.3 Brucella Abortus Vaccine Market Challenges
1.3.4 Brucella Abortus Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Brucella Abortus Vaccine Players Revenue Ranking (2023)
2.2 Global Brucella Abortus Vaccine Revenue by Company (2019-2024)
2.3 Global Brucella Abortus Vaccine Players Sales Volume Ranking (2023)
2.4 Global Brucella Abortus Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Brucella Abortus Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Brucella Abortus Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Brucella Abortus Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Brucella Abortus Vaccine
2.9 Brucella Abortus Vaccine Market Competitive Analysis
2.9.1 Brucella Abortus Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Brucella Abortus Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucella Abortus Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 DNA Vaccines
3.1.2 Subunit Vaccines
3.1.3 Vector Vaccines
3.1.4 B. Abortus Recombinant Mutants
3.1.5 Others
3.2 Global Brucella Abortus Vaccine Sales Value by Type
3.2.1 Global Brucella Abortus Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Brucella Abortus Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Brucella Abortus Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Brucella Abortus Vaccine Sales Volume by Type
3.3.1 Global Brucella Abortus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Brucella Abortus Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Brucella Abortus Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Brucella Abortus Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cattles
4.1.2 Sheep
4.1.3 Pigs
4.1.4 Others
4.2 Global Brucella Abortus Vaccine Sales Value by Application
4.2.1 Global Brucella Abortus Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Brucella Abortus Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Brucella Abortus Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Brucella Abortus Vaccine Sales Volume by Application
4.3.1 Global Brucella Abortus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Brucella Abortus Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Brucella Abortus Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Brucella Abortus Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Brucella Abortus Vaccine Sales Value by Region
5.1.1 Global Brucella Abortus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Brucella Abortus Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Brucella Abortus Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Brucella Abortus Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Brucella Abortus Vaccine Sales Volume by Region
5.2.1 Global Brucella Abortus Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Brucella Abortus Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Brucella Abortus Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Brucella Abortus Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Brucella Abortus Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Brucella Abortus Vaccine Sales Value, 2019-2030
5.4.2 North America Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Brucella Abortus Vaccine Sales Value, 2019-2030
5.5.2 Europe Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Brucella Abortus Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Brucella Abortus Vaccine Sales Value, 2019-2030
5.7.2 South America Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Brucella Abortus Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Brucella Abortus Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Brucella Abortus Vaccine Sales Value
6.2.1 Key Countries/Regions Brucella Abortus Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Brucella Abortus Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Brucella Abortus Vaccine Sales Value, 2019-2030
6.3.2 United States Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Brucella Abortus Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Brucella Abortus Vaccine Sales Value, 2019-2030
6.4.2 Europe Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Brucella Abortus Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Brucella Abortus Vaccine Sales Value, 2019-2030
6.5.2 China Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Brucella Abortus Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Brucella Abortus Vaccine Sales Value, 2019-2030
6.6.2 Japan Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Brucella Abortus Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Brucella Abortus Vaccine Sales Value, 2019-2030
6.7.2 South Korea Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Brucella Abortus Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Brucella Abortus Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Brucella Abortus Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Brucella Abortus Vaccine Sales Value, 2019-2030
6.9.2 India Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Brucella Abortus Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Company Information
7.1.2 Zoetis Introduction and Business Overview
7.1.3 Zoetis Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Zoetis Brucella Abortus Vaccine Product Offerings
7.1.5 Zoetis Recent Development
7.2 CEVA
7.2.1 CEVA Company Information
7.2.2 CEVA Introduction and Business Overview
7.2.3 CEVA Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 CEVA Brucella Abortus Vaccine Product Offerings
7.2.5 CEVA Recent Development
7.3 Merck Animal Health
7.3.1 Merck Animal Health Company Information
7.3.2 Merck Animal Health Introduction and Business Overview
7.3.3 Merck Animal Health Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Merck Animal Health Brucella Abortus Vaccine Product Offerings
7.3.5 Merck Animal Health Recent Development
7.4 Biovet
7.4.1 Biovet Company Information
7.4.2 Biovet Introduction and Business Overview
7.4.3 Biovet Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Biovet Brucella Abortus Vaccine Product Offerings
7.4.5 Biovet Recent Development
7.5 CAVAC
7.5.1 CAVAC Company Information
7.5.2 CAVAC Introduction and Business Overview
7.5.3 CAVAC Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 CAVAC Brucella Abortus Vaccine Product Offerings
7.5.5 CAVAC Recent Development
7.6 JOVAC
7.6.1 JOVAC Company Information
7.6.2 JOVAC Introduction and Business Overview
7.6.3 JOVAC Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 JOVAC Brucella Abortus Vaccine Product Offerings
7.6.5 JOVAC Recent Development
7.7 Merial
7.7.1 Merial Company Information
7.7.2 Merial Introduction and Business Overview
7.7.3 Merial Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Merial Brucella Abortus Vaccine Product Offerings
7.7.5 Merial Recent Development
7.8 Colorado Serum Company
7.8.1 Colorado Serum Company Company Information
7.8.2 Colorado Serum Company Introduction and Business Overview
7.8.3 Colorado Serum Company Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Colorado Serum Company Brucella Abortus Vaccine Product Offerings
7.8.5 Colorado Serum Company Recent Development
7.9 VECOL
7.9.1 VECOL Company Information
7.9.2 VECOL Introduction and Business Overview
7.9.3 VECOL Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 VECOL Brucella Abortus Vaccine Product Offerings
7.9.5 VECOL Recent Development
7.10 Tecnovax
7.10.1 Tecnovax Company Information
7.10.2 Tecnovax Introduction and Business Overview
7.10.3 Tecnovax Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Tecnovax Brucella Abortus Vaccine Product Offerings
7.10.5 Tecnovax Recent Development
7.11 Indian Immunologicals
7.11.1 Indian Immunologicals Company Information
7.11.2 Indian Immunologicals Introduction and Business Overview
7.11.3 Indian Immunologicals Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Indian Immunologicals Brucella Abortus Vaccine Product Offerings
7.11.5 Indian Immunologicals Recent Development
7.12 Vetal
7.12.1 Vetal Company Information
7.12.2 Vetal Introduction and Business Overview
7.12.3 Vetal Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Vetal Brucella Abortus Vaccine Product Offerings
7.12.5 Vetal Recent Development
7.13 Dollvet
7.13.1 Dollvet Company Information
7.13.2 Dollvet Introduction and Business Overview
7.13.3 Dollvet Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Dollvet Brucella Abortus Vaccine Product Offerings
7.13.5 Dollvet Recent Development
7.14 Centro Diagnostico Veterinario
7.14.1 Centro Diagnostico Veterinario Company Information
7.14.2 Centro Diagnostico Veterinario Introduction and Business Overview
7.14.3 Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Offerings
7.14.5 Centro Diagnostico Veterinario Recent Development
7.15 Onderstepoort Biological Products
7.15.1 Onderstepoort Biological Products Company Information
7.15.2 Onderstepoort Biological Products Introduction and Business Overview
7.15.3 Onderstepoort Biological Products Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Onderstepoort Biological Products Brucella Abortus Vaccine Product Offerings
7.15.5 Onderstepoort Biological Products Recent Development
7.16 Institute of Animal Health and Veterinary Biologicals
7.16.1 Institute of Animal Health and Veterinary Biologicals Company Information
7.16.2 Institute of Animal Health and Veterinary Biologicals Introduction and Business Overview
7.16.3 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Offerings
7.16.5 Institute of Animal Health and Veterinary Biologicals Recent Development
7.17 Biogenesis Bago
7.17.1 Biogenesis Bago Company Information
7.17.2 Biogenesis Bago Introduction and Business Overview
7.17.3 Biogenesis Bago Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Biogenesis Bago Brucella Abortus Vaccine Product Offerings
7.17.5 Biogenesis Bago Recent Development
7.18 Instituto Rosenbusch
7.18.1 Instituto Rosenbusch Company Information
7.18.2 Instituto Rosenbusch Introduction and Business Overview
7.18.3 Instituto Rosenbusch Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Instituto Rosenbusch Brucella Abortus Vaccine Product Offerings
7.18.5 Instituto Rosenbusch Recent Development
7.19 SYVA Laboratorios
7.19.1 SYVA Laboratorios Company Information
7.19.2 SYVA Laboratorios Introduction and Business Overview
7.19.3 SYVA Laboratorios Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.19.4 SYVA Laboratorios Brucella Abortus Vaccine Product Offerings
7.19.5 SYVA Laboratorios Recent Development
7.20 CZ Veterinaria
7.20.1 CZ Veterinaria Company Information
7.20.2 CZ Veterinaria Introduction and Business Overview
7.20.3 CZ Veterinaria Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.20.4 CZ Veterinaria Brucella Abortus Vaccine Product Offerings
7.20.5 CZ Veterinaria Recent Development
7.21 Hester Biosciences
7.21.1 Hester Biosciences Company Information
7.21.2 Hester Biosciences Introduction and Business Overview
7.21.3 Hester Biosciences Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Hester Biosciences Brucella Abortus Vaccine Product Offerings
7.21.5 Hester Biosciences Recent Development
7.22 Qilu Animal Health
7.22.1 Qilu Animal Health Company Information
7.22.2 Qilu Animal Health Introduction and Business Overview
7.22.3 Qilu Animal Health Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Qilu Animal Health Brucella Abortus Vaccine Product Offerings
7.22.5 Qilu Animal Health Recent Development
8 Industry Chain Analysis
8.1 Brucella Abortus Vaccine Industrial Chain
8.2 Brucella Abortus Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Brucella Abortus Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Brucella Abortus Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Brucella Abortus Vaccine Market Trends
Table 2. Brucella Abortus Vaccine Market Drivers & Opportunity
Table 3. Brucella Abortus Vaccine Market Challenges
Table 4. Brucella Abortus Vaccine Market Restraints
Table 5. Global Brucella Abortus Vaccine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Brucella Abortus Vaccine Revenue Market Share by Company (2019-2024)
Table 7. Global Brucella Abortus Vaccine Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Brucella Abortus Vaccine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Brucella Abortus Vaccine Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Brucella Abortus Vaccine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Brucella Abortus Vaccine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Brucella Abortus Vaccine
Table 13. Global Brucella Abortus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucella Abortus Vaccine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Brucella Abortus Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Brucella Abortus Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Brucella Abortus Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Brucella Abortus Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Brucella Abortus Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Brucella Abortus Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Brucella Abortus Vaccine Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Brucella Abortus Vaccine Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Brucella Abortus Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Brucella Abortus Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Brucella Abortus Vaccine Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Brucella Abortus Vaccine Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Brucella Abortus Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Brucella Abortus Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Brucella Abortus Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Brucella Abortus Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Brucella Abortus Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Brucella Abortus Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Brucella Abortus Vaccine Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Brucella Abortus Vaccine Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Brucella Abortus Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Brucella Abortus Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Brucella Abortus Vaccine Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Brucella Abortus Vaccine Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Brucella Abortus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Brucella Abortus Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Brucella Abortus Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Brucella Abortus Vaccine Sales Value by Region (2019-2024) & (%)
Table 44. Global Brucella Abortus Vaccine Sales Value by Region (2025-2030) & (%)
Table 45. Global Brucella Abortus Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Brucella Abortus Vaccine Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Brucella Abortus Vaccine Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Brucella Abortus Vaccine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Brucella Abortus Vaccine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Brucella Abortus Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Brucella Abortus Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Brucella Abortus Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Brucella Abortus Vaccine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Brucella Abortus Vaccine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Brucella Abortus Vaccine Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Brucella Abortus Vaccine Sales Volume, (2025-2030) & (K Units)
Table 57. Zoetis Company Information
Table 58. Zoetis Introduction and Business Overview
Table 59. Zoetis Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Zoetis Brucella Abortus Vaccine Product Offerings
Table 61. Zoetis Recent Development
Table 62. CEVA Company Information
Table 63. CEVA Introduction and Business Overview
Table 64. CEVA Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. CEVA Brucella Abortus Vaccine Product Offerings
Table 66. CEVA Recent Development
Table 67. Merck Animal Health Company Information
Table 68. Merck Animal Health Introduction and Business Overview
Table 69. Merck Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Merck Animal Health Brucella Abortus Vaccine Product Offerings
Table 71. Merck Animal Health Recent Development
Table 72. Biovet Company Information
Table 73. Biovet Introduction and Business Overview
Table 74. Biovet Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Biovet Brucella Abortus Vaccine Product Offerings
Table 76. Biovet Recent Development
Table 77. CAVAC Company Information
Table 78. CAVAC Introduction and Business Overview
Table 79. CAVAC Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. CAVAC Brucella Abortus Vaccine Product Offerings
Table 81. CAVAC Recent Development
Table 82. JOVAC Company Information
Table 83. JOVAC Introduction and Business Overview
Table 84. JOVAC Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. JOVAC Brucella Abortus Vaccine Product Offerings
Table 86. JOVAC Recent Development
Table 87. Merial Company Information
Table 88. Merial Introduction and Business Overview
Table 89. Merial Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Merial Brucella Abortus Vaccine Product Offerings
Table 91. Merial Recent Development
Table 92. Colorado Serum Company Company Information
Table 93. Colorado Serum Company Introduction and Business Overview
Table 94. Colorado Serum Company Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Colorado Serum Company Brucella Abortus Vaccine Product Offerings
Table 96. Colorado Serum Company Recent Development
Table 97. VECOL Company Information
Table 98. VECOL Introduction and Business Overview
Table 99. VECOL Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. VECOL Brucella Abortus Vaccine Product Offerings
Table 101. VECOL Recent Development
Table 102. Tecnovax Company Information
Table 103. Tecnovax Introduction and Business Overview
Table 104. Tecnovax Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Tecnovax Brucella Abortus Vaccine Product Offerings
Table 106. Tecnovax Recent Development
Table 107. Indian Immunologicals Company Information
Table 108. Indian Immunologicals Introduction and Business Overview
Table 109. Indian Immunologicals Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Indian Immunologicals Brucella Abortus Vaccine Product Offerings
Table 111. Indian Immunologicals Recent Development
Table 112. Vetal Company Information
Table 113. Vetal Introduction and Business Overview
Table 114. Vetal Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Vetal Brucella Abortus Vaccine Product Offerings
Table 116. Vetal Recent Development
Table 117. Dollvet Company Information
Table 118. Dollvet Introduction and Business Overview
Table 119. Dollvet Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Dollvet Brucella Abortus Vaccine Product Offerings
Table 121. Dollvet Recent Development
Table 122. Centro Diagnostico Veterinario Company Information
Table 123. Centro Diagnostico Veterinario Introduction and Business Overview
Table 124. Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Offerings
Table 126. Centro Diagnostico Veterinario Recent Development
Table 127. Onderstepoort Biological Products Company Information
Table 128. Onderstepoort Biological Products Introduction and Business Overview
Table 129. Onderstepoort Biological Products Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Onderstepoort Biological Products Brucella Abortus Vaccine Product Offerings
Table 131. Onderstepoort Biological Products Recent Development
Table 132. Institute of Animal Health and Veterinary Biologicals Company Information
Table 133. Institute of Animal Health and Veterinary Biologicals Introduction and Business Overview
Table 134. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Offerings
Table 136. Institute of Animal Health and Veterinary Biologicals Recent Development
Table 137. Biogenesis Bago Company Information
Table 138. Biogenesis Bago Introduction and Business Overview
Table 139. Biogenesis Bago Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Biogenesis Bago Brucella Abortus Vaccine Product Offerings
Table 141. Biogenesis Bago Recent Development
Table 142. Instituto Rosenbusch Company Information
Table 143. Instituto Rosenbusch Introduction and Business Overview
Table 144. Instituto Rosenbusch Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. Instituto Rosenbusch Brucella Abortus Vaccine Product Offerings
Table 146. Instituto Rosenbusch Recent Development
Table 147. SYVA Laboratorios Company Information
Table 148. SYVA Laboratorios Introduction and Business Overview
Table 149. SYVA Laboratorios Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 150. SYVA Laboratorios Brucella Abortus Vaccine Product Offerings
Table 151. SYVA Laboratorios Recent Development
Table 152. CZ Veterinaria Company Information
Table 153. CZ Veterinaria Introduction and Business Overview
Table 154. CZ Veterinaria Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 155. CZ Veterinaria Brucella Abortus Vaccine Product Offerings
Table 156. CZ Veterinaria Recent Development
Table 157. Hester Biosciences Company Information
Table 158. Hester Biosciences Introduction and Business Overview
Table 159. Hester Biosciences Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 160. Hester Biosciences Brucella Abortus Vaccine Product Offerings
Table 161. Hester Biosciences Recent Development
Table 162. Qilu Animal Health Company Information
Table 163. Qilu Animal Health Introduction and Business Overview
Table 164. Qilu Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 165. Qilu Animal Health Brucella Abortus Vaccine Product Offerings
Table 166. Qilu Animal Health Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Brucella Abortus Vaccine Downstream Customers
Table 170. Brucella Abortus Vaccine Distributors List
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Brucella Abortus Vaccine Product Picture
Figure 2. Global Brucella Abortus Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Brucella Abortus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Brucella Abortus Vaccine Sales Volume (2019-2030) & (K Units)
Figure 5. Global Brucella Abortus Vaccine Sales Price (2019-2030) & (US$/Unit)
Figure 6. Brucella Abortus Vaccine Report Years Considered
Figure 7. Global Brucella Abortus Vaccine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Brucella Abortus Vaccine Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Brucella Abortus Vaccine Revenue in 2023
Figure 10. Brucella Abortus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. DNA Vaccines Picture
Figure 12. Subunit Vaccines Picture
Figure 13. Vector Vaccines Picture
Figure 14. B. Abortus Recombinant Mutants Picture
Figure 15. Others Picture
Figure 16. Global Brucella Abortus Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Brucella Abortus Vaccine Sales Value Market Share by Type, 2023 & 2030
Figure 18. Global Brucella Abortus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 19. Global Brucella Abortus Vaccine Sales Volume Market Share by Type, 2023 & 2030
Figure 20. Global Brucella Abortus Vaccine Price by Type (2019-2030) & (US$/Unit)
Figure 21. Product Picture of Cattles
Figure 22. Product Picture of Sheep
Figure 23. Product Picture of Pigs
Figure 24. Product Picture of Others
Figure 25. Global Brucella Abortus Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 26. Global Brucella Abortus Vaccine Sales Value Market Share by Application, 2023 & 2030
Figure 27. Global Brucella Abortus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 28. Global Brucella Abortus Vaccine Sales Volume Market Share by Application, 2023 & 2030
Figure 29. Global Brucella Abortus Vaccine Price by Application (2019-2030) & (US$/Unit)
Figure 30. North America Brucella Abortus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 31. North America Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 32. Europe Brucella Abortus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 34. Asia Pacific Brucella Abortus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 36. South America Brucella Abortus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 37. South America Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa Brucella Abortus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 40. Key Countries/Regions Brucella Abortus Vaccine Sales Value (%), (2019-2030)
Figure 41. Key Countries/Regions Brucella Abortus Vaccine Sales Volume (%), (2019-2030)
Figure 42. United States Brucella Abortus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 43. United States Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 44. United States Brucella Abortus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 45. Europe Brucella Abortus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 46. Europe Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 47. Europe Brucella Abortus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 48. China Brucella Abortus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 49. China Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 50. China Brucella Abortus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 51. Japan Brucella Abortus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 52. Japan Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 53. Japan Brucella Abortus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 54. South Korea Brucella Abortus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 55. South Korea Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 56. South Korea Brucella Abortus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 57. Southeast Asia Brucella Abortus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 58. Southeast Asia Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 59. Southeast Asia Brucella Abortus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 60. India Brucella Abortus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 61. India Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 62. India Brucella Abortus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 63. Brucella Abortus Vaccine Industrial Chain
Figure 64. Brucella Abortus Vaccine Manufacturing Cost Structure
Figure 65. Channels of Distribution (Direct Sales, and Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Brucella Abortus Vaccine Market Trends
Table 2. Brucella Abortus Vaccine Market Drivers & Opportunity
Table 3. Brucella Abortus Vaccine Market Challenges
Table 4. Brucella Abortus Vaccine Market Restraints
Table 5. Global Brucella Abortus Vaccine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Brucella Abortus Vaccine Revenue Market Share by Company (2019-2024)
Table 7. Global Brucella Abortus Vaccine Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Brucella Abortus Vaccine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Brucella Abortus Vaccine Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Brucella Abortus Vaccine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Brucella Abortus Vaccine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Brucella Abortus Vaccine
Table 13. Global Brucella Abortus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucella Abortus Vaccine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Brucella Abortus Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Brucella Abortus Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Brucella Abortus Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Brucella Abortus Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Brucella Abortus Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Brucella Abortus Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Brucella Abortus Vaccine Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Brucella Abortus Vaccine Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Brucella Abortus Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Brucella Abortus Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Brucella Abortus Vaccine Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Brucella Abortus Vaccine Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Brucella Abortus Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Brucella Abortus Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Brucella Abortus Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Brucella Abortus Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Brucella Abortus Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Brucella Abortus Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Brucella Abortus Vaccine Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Brucella Abortus Vaccine Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Brucella Abortus Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Brucella Abortus Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Brucella Abortus Vaccine Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Brucella Abortus Vaccine Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Brucella Abortus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Brucella Abortus Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Brucella Abortus Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Brucella Abortus Vaccine Sales Value by Region (2019-2024) & (%)
Table 44. Global Brucella Abortus Vaccine Sales Value by Region (2025-2030) & (%)
Table 45. Global Brucella Abortus Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Brucella Abortus Vaccine Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Brucella Abortus Vaccine Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Brucella Abortus Vaccine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Brucella Abortus Vaccine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Brucella Abortus Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Brucella Abortus Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Brucella Abortus Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Brucella Abortus Vaccine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Brucella Abortus Vaccine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Brucella Abortus Vaccine Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Brucella Abortus Vaccine Sales Volume, (2025-2030) & (K Units)
Table 57. Zoetis Company Information
Table 58. Zoetis Introduction and Business Overview
Table 59. Zoetis Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Zoetis Brucella Abortus Vaccine Product Offerings
Table 61. Zoetis Recent Development
Table 62. CEVA Company Information
Table 63. CEVA Introduction and Business Overview
Table 64. CEVA Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. CEVA Brucella Abortus Vaccine Product Offerings
Table 66. CEVA Recent Development
Table 67. Merck Animal Health Company Information
Table 68. Merck Animal Health Introduction and Business Overview
Table 69. Merck Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Merck Animal Health Brucella Abortus Vaccine Product Offerings
Table 71. Merck Animal Health Recent Development
Table 72. Biovet Company Information
Table 73. Biovet Introduction and Business Overview
Table 74. Biovet Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Biovet Brucella Abortus Vaccine Product Offerings
Table 76. Biovet Recent Development
Table 77. CAVAC Company Information
Table 78. CAVAC Introduction and Business Overview
Table 79. CAVAC Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. CAVAC Brucella Abortus Vaccine Product Offerings
Table 81. CAVAC Recent Development
Table 82. JOVAC Company Information
Table 83. JOVAC Introduction and Business Overview
Table 84. JOVAC Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. JOVAC Brucella Abortus Vaccine Product Offerings
Table 86. JOVAC Recent Development
Table 87. Merial Company Information
Table 88. Merial Introduction and Business Overview
Table 89. Merial Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Merial Brucella Abortus Vaccine Product Offerings
Table 91. Merial Recent Development
Table 92. Colorado Serum Company Company Information
Table 93. Colorado Serum Company Introduction and Business Overview
Table 94. Colorado Serum Company Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Colorado Serum Company Brucella Abortus Vaccine Product Offerings
Table 96. Colorado Serum Company Recent Development
Table 97. VECOL Company Information
Table 98. VECOL Introduction and Business Overview
Table 99. VECOL Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. VECOL Brucella Abortus Vaccine Product Offerings
Table 101. VECOL Recent Development
Table 102. Tecnovax Company Information
Table 103. Tecnovax Introduction and Business Overview
Table 104. Tecnovax Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Tecnovax Brucella Abortus Vaccine Product Offerings
Table 106. Tecnovax Recent Development
Table 107. Indian Immunologicals Company Information
Table 108. Indian Immunologicals Introduction and Business Overview
Table 109. Indian Immunologicals Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Indian Immunologicals Brucella Abortus Vaccine Product Offerings
Table 111. Indian Immunologicals Recent Development
Table 112. Vetal Company Information
Table 113. Vetal Introduction and Business Overview
Table 114. Vetal Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Vetal Brucella Abortus Vaccine Product Offerings
Table 116. Vetal Recent Development
Table 117. Dollvet Company Information
Table 118. Dollvet Introduction and Business Overview
Table 119. Dollvet Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Dollvet Brucella Abortus Vaccine Product Offerings
Table 121. Dollvet Recent Development
Table 122. Centro Diagnostico Veterinario Company Information
Table 123. Centro Diagnostico Veterinario Introduction and Business Overview
Table 124. Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Offerings
Table 126. Centro Diagnostico Veterinario Recent Development
Table 127. Onderstepoort Biological Products Company Information
Table 128. Onderstepoort Biological Products Introduction and Business Overview
Table 129. Onderstepoort Biological Products Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Onderstepoort Biological Products Brucella Abortus Vaccine Product Offerings
Table 131. Onderstepoort Biological Products Recent Development
Table 132. Institute of Animal Health and Veterinary Biologicals Company Information
Table 133. Institute of Animal Health and Veterinary Biologicals Introduction and Business Overview
Table 134. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Offerings
Table 136. Institute of Animal Health and Veterinary Biologicals Recent Development
Table 137. Biogenesis Bago Company Information
Table 138. Biogenesis Bago Introduction and Business Overview
Table 139. Biogenesis Bago Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Biogenesis Bago Brucella Abortus Vaccine Product Offerings
Table 141. Biogenesis Bago Recent Development
Table 142. Instituto Rosenbusch Company Information
Table 143. Instituto Rosenbusch Introduction and Business Overview
Table 144. Instituto Rosenbusch Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. Instituto Rosenbusch Brucella Abortus Vaccine Product Offerings
Table 146. Instituto Rosenbusch Recent Development
Table 147. SYVA Laboratorios Company Information
Table 148. SYVA Laboratorios Introduction and Business Overview
Table 149. SYVA Laboratorios Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 150. SYVA Laboratorios Brucella Abortus Vaccine Product Offerings
Table 151. SYVA Laboratorios Recent Development
Table 152. CZ Veterinaria Company Information
Table 153. CZ Veterinaria Introduction and Business Overview
Table 154. CZ Veterinaria Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 155. CZ Veterinaria Brucella Abortus Vaccine Product Offerings
Table 156. CZ Veterinaria Recent Development
Table 157. Hester Biosciences Company Information
Table 158. Hester Biosciences Introduction and Business Overview
Table 159. Hester Biosciences Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 160. Hester Biosciences Brucella Abortus Vaccine Product Offerings
Table 161. Hester Biosciences Recent Development
Table 162. Qilu Animal Health Company Information
Table 163. Qilu Animal Health Introduction and Business Overview
Table 164. Qilu Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 165. Qilu Animal Health Brucella Abortus Vaccine Product Offerings
Table 166. Qilu Animal Health Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Brucella Abortus Vaccine Downstream Customers
Table 170. Brucella Abortus Vaccine Distributors List
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Brucella Abortus Vaccine Product Picture
Figure 2. Global Brucella Abortus Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Brucella Abortus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Brucella Abortus Vaccine Sales Volume (2019-2030) & (K Units)
Figure 5. Global Brucella Abortus Vaccine Sales Price (2019-2030) & (US$/Unit)
Figure 6. Brucella Abortus Vaccine Report Years Considered
Figure 7. Global Brucella Abortus Vaccine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Brucella Abortus Vaccine Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Brucella Abortus Vaccine Revenue in 2023
Figure 10. Brucella Abortus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. DNA Vaccines Picture
Figure 12. Subunit Vaccines Picture
Figure 13. Vector Vaccines Picture
Figure 14. B. Abortus Recombinant Mutants Picture
Figure 15. Others Picture
Figure 16. Global Brucella Abortus Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Brucella Abortus Vaccine Sales Value Market Share by Type, 2023 & 2030
Figure 18. Global Brucella Abortus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 19. Global Brucella Abortus Vaccine Sales Volume Market Share by Type, 2023 & 2030
Figure 20. Global Brucella Abortus Vaccine Price by Type (2019-2030) & (US$/Unit)
Figure 21. Product Picture of Cattles
Figure 22. Product Picture of Sheep
Figure 23. Product Picture of Pigs
Figure 24. Product Picture of Others
Figure 25. Global Brucella Abortus Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 26. Global Brucella Abortus Vaccine Sales Value Market Share by Application, 2023 & 2030
Figure 27. Global Brucella Abortus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 28. Global Brucella Abortus Vaccine Sales Volume Market Share by Application, 2023 & 2030
Figure 29. Global Brucella Abortus Vaccine Price by Application (2019-2030) & (US$/Unit)
Figure 30. North America Brucella Abortus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 31. North America Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 32. Europe Brucella Abortus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 34. Asia Pacific Brucella Abortus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 36. South America Brucella Abortus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 37. South America Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa Brucella Abortus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa Brucella Abortus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 40. Key Countries/Regions Brucella Abortus Vaccine Sales Value (%), (2019-2030)
Figure 41. Key Countries/Regions Brucella Abortus Vaccine Sales Volume (%), (2019-2030)
Figure 42. United States Brucella Abortus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 43. United States Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 44. United States Brucella Abortus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 45. Europe Brucella Abortus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 46. Europe Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 47. Europe Brucella Abortus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 48. China Brucella Abortus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 49. China Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 50. China Brucella Abortus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 51. Japan Brucella Abortus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 52. Japan Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 53. Japan Brucella Abortus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 54. South Korea Brucella Abortus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 55. South Korea Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 56. South Korea Brucella Abortus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 57. Southeast Asia Brucella Abortus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 58. Southeast Asia Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 59. Southeast Asia Brucella Abortus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 60. India Brucella Abortus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 61. India Brucella Abortus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 62. India Brucella Abortus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 63. Brucella Abortus Vaccine Industrial Chain
Figure 64. Brucella Abortus Vaccine Manufacturing Cost Structure
Figure 65. Channels of Distribution (Direct Sales, and Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232